Randomised open trial
Showing 1 - 25 of >10,000
Extracorporeal Membrane Oxygenation Complication Trial in Sydney (Unfractionated heparin, Bivalirudin)
Not yet recruiting
- Extracorporeal Membrane Oxygenation Complication
- Unfractionated heparin
- Bivalirudin
-
Sydney, New South Wales, AustraliaRoyal Prince Alfred Hospital
Jul 26, 2023
Plasmodium Falciparum Malaria Trial in Bandarban, Lama (DHA/piperaquine and a SLD-PQ, Study vaccine R21/Matrix-M™)
Not yet recruiting
- Plasmodium Falciparum Malaria
- DHA/piperaquine and a SLD-PQ
- Study vaccine R21/Matrix-M™
-
Bāndarban, Bangladesh
- +1 more
Sep 28, 2023
Acute Ischemic Stroke Trial (Ginkgo Biloba Extract)
Not yet recruiting
- Acute Ischemic Stroke
- Ginkgo Biloba Extract
- (no location specified)
Nov 20, 2023
Non-alcoholic Steatohepatitis, Type 2 Diabetes (T2DM), Chronic Kidney Disease Trial in Ruddington (cotadutide solution for
Completed
- Non-alcoholic Steatohepatitis
- +2 more
- cotadutide solution for injection
-
Ruddington, United KingdomResearch Site
Sep 30, 2022
Transradial Access Trial in Nanjing (transradial access, Transfemoral access)
Not yet recruiting
- Transradial Access
- transradial access
- Transfemoral access
-
Nanjing, ChinaJiangsu Province Hospital
May 7, 2023
Pleural Infection Trial (Intrapleural fibrinolytic with alteplase 5mg and pulmozyme 5 mg, Saline irrigation with 250 mls normal
Not yet recruiting
- Pleural Infection
- Intrapleural fibrinolytic with alteplase 5mg and pulmozyme 5 mg
- Saline irrigation with 250 mls normal saline (over 1 hour)
- (no location specified)
Jun 19, 2023
Burns Trial (FibDex, Epicite hydro, Epiprotect)
Not yet recruiting
- Burns
- FibDex
- +2 more
- (no location specified)
Nov 16, 2022
Healthy Subjects Trial (Test Formula, Control Formula)
Not yet recruiting
- Healthy Subjects
- Test Formula
- Control Formula
- (no location specified)
Nov 7, 2023
Healthy Trial in London (NTP42:KVA4 Capsule, NTP42:KVA4 Liquid)
Recruiting
- Healthy
- NTP42:KVA4 Capsule
- NTP42:KVA4 Liquid
-
London, United KingdomHammersmith Medicines Research
Oct 20, 2023
Acute Ischemic Stroke Trial in Changchun (Urinary kallidinogenase for injection, Guideline-prescribed medical therapy)
Not yet recruiting
- Acute Ischemic Stroke
- Urinary kallidinogenase for injection
- Guideline-prescribed medical therapy
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Nov 14, 2023
Healthy Trial (BI 3000202, Placebo matching BI 3000202)
Not yet recruiting
- Healthy
- BI 3000202
- Placebo matching BI 3000202
- (no location specified)
Jul 7, 2023
Hepatic Impairment, Pharmacokinetics Trial in Jilin (ZSP1273)
Not yet recruiting
- Hepatic Impairment
- Pharmacokinetics
-
Jilin, ChinaThe First Hospital of Jilin University
May 4, 2023
Lung Cancer, Nonsmall Cell Trial in United Kingdom (Pembrolizumab 25 MG/ML [Keytruda])
Recruiting
- Lung Cancer, Nonsmall Cell
- Pembrolizumab 25 MG/ML [Keytruda]
-
Manchester, United Kingdom
- +3 more
Aug 4, 2022
Hernia, Inguinal Trial (Erector spinae plane block)
Not yet recruiting
- Hernia, Inguinal
- Erector spinae plane block
- (no location specified)
Nov 30, 2023
Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)
Not yet recruiting
- Steroid-refractory Acute Graft-versus-host Disease
- MC0518
- BAT
- (no location specified)
Oct 4, 2023
Postoperative Pain, Gynecologic Disease, Local Anesthetic Systemic Toxicity Trial in Kuala Lumpur (Lignocaine, Normal Saline)
Not yet recruiting
- Postoperative Pain
- +2 more
- Lignocaine
- Normal Saline
-
Kuala Lumpur, MalaysiaUniversity of Malaya
May 31, 2023
Triple Negative Breast Cancer Trial in London (Atezolizumab, Ipatasertib, Paclitaxel)
Active, not recruiting
- Triple Negative Breast Cancer
- Atezolizumab
- +4 more
-
London, United KingdomBarts Health NHS Trust
Aug 10, 2022
Coronary Artery Disease Trial (Lansoprazole 15 mg)
Not yet recruiting
- Coronary Artery Disease
- Lansoprazole 15 mg
- (no location specified)
Apr 6, 2023
Malaria Trial in Mae Sot (dihydroartemisinin-piperaquine, Artesunate-mefloquine, arthemeter-lumefantrin)
Completed
- Malaria
- dihydroartemisinin-piperaquine
- +2 more
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit
Mar 24, 2022
Advanced Prostate Cancer Trial in Visakhapatnam (Inj. Goserelin (Test) Subcutaneously, Inj. Zoladex (Reference) Subcutaneously)
Recruiting
- Advanced Prostate Cancer
- Inj. Goserelin (Test) Subcutaneously
- Inj. Zoladex (Reference) Subcutaneously
-
Visakhapatnam, Andhra Pradesh, IndiaMahatma Gandhi Cancer Hospital & Research Institute
Nov 29, 2022